(Q51434937)

English

From Molecular Docking to 3D-Quantitative Structure-Activity Relationships (3D-QSAR): Insights into the Binding Mode of 5-Lipoxygenase Inhibitors.

scientific article published on 20 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27476957%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

From Molecular Docking to 3D-Quantitative Structure-Activity Relationships (3D-QSAR): Insights into the Binding Mode of 5-Lipoxygenase Inhibitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27476957%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Antonio Macchiarulo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27476957%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27476957%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27476957%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Gokcen Eren

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/27476957

Erden Banoglu

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/27476957

publication date

20 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27476957%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Molecular Informatics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27476957%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27476957%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27476957%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

123-134

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27476957%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

5-Lipoxygenase: regulation of expression and enzyme activity

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Therapeutic options for 5-lipoxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

5-Lipoxygenase inhibitors: a review of recent developments and patents

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybrids.

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics of L-739,010.

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Substituted coumarins as potent 5-lipoxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Structural optimization and biological evaluation of 2-substituted 5-hydroxyindole-3-carboxylates as potent inhibitors of human 5-lipoxygenase.

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

The discovery of setileuton, a potent and selective 5-lipoxygenase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Potent and selective 5-LO inhibitor bearing benzothiophene pharmacophore: discovery of MK-5286.

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents.

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

The structure of human 5-lipoxygenase

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Improved protein-ligand docking using GOLD

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Computational models to assign biopharmaceutics drug disposition classification from molecular structure

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

Machine learning methods and docking for predicting human pregnane X receptor activation

1 reference

https://api.crossref.org/works/10.1002%2FMINF.201100101

21 January 2018

A novel class of dual mPGES-1/5-LO inhibitors based on the α-naphthyl pirinixic acid scaffold

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201100101

8 April 2023

Thiopyranol[2,3,4-c,d]indoles as inhibitors of 5-lipoxygenase, 5-lipoxygenase-activating protein, and leukotriene C4 synthase

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201100101

8 April 2023

Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201100101

8 April 2023

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201100101

8 April 2023

Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1002/MINF.201100101

8 April 2023

Identifiers

10.1002/MINF.201100101

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27476957%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27476957%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51434937&oldid=1870858185"